Home / Ropivacaine / Belgium
BE ATC N01BB09 · updated 2 Nov 2026
Ropivacaine shortage in Belgium
Is there a Ropivacaine shortage in Belgium?
Yes. As of 2 Nov 2026, 7 Ropivacaine products are reported short in Belgium, the first since 22 Oct 2021. The company estimate for the return is 29 Nov 2026 (latest 28 May 2027). Main reason: manufacturing problem.
Also short in United States, Germany, Italy, Spain, Austria, Czechia, Sweden, New Zealand. All countries.
Affected products in Belgium
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| BE | Ropivacaine Readyfusor 2 mg/ml inf. sol. (administr. system) 250 ml | BioQ Pharma | 22 Oct 2021 | not given | Other Other reason |
| BE | Ropivacaine Readyfusor 2 mg/ml inf. sol. (administr. system) 250 ml | BioQ Pharma | 22 Oct 2021 | not given | Manufacturing problem Delay in production |
| BE | Ropivacaine Readyfusor 2 mg/ml inf. sol. (administr. system) 250 ml | BioQ Pharma | 22 Oct 2021 | not given | Manufacturing problem Delay in production |
| BE | Naropin 2 mg/ml inj. sol. epidur. amp. 5 x 20 ml | Sandoz | 20 Apr 2026 | 5 Feb 2027 | Increased demand |
| BE | Ropivacaine Fresenius Kabi 7.5 mg/ml inj. sol. epidur. amp. 5 x 20 ml | Fresenius Kabi | 19 Aug 2026 | 29 Nov 2026 | Manufacturing problem Delay in production |
| BE | Ropivacaine Fresenius Kabi 5 mg/ml inj. sol. i.thec. amp. 5 x 10 ml | Fresenius Kabi | 8 Oct 2026 | 7 Feb 2027 | Manufacturing problem Delay in production |
| BE | Naropin 5 mg/ml inj. sol. i.thec. amp. 5 x 10 ml | Sandoz | 29 Oct 2026 | 28 May 2027 | Increased demand |
Source
FAMHP (Federal Agency for Medicines and Health Products), PharmaStatus / SAMv2. Official list. All authorised packs with a declared temporary unavailability.